Videos

Search

Saved Activities

 x 

0 Activities
0 Activities

2019 Summer Pulmonary Updates: The Experts Weigh In

Array

Activity Info

This activity is intended for ILD experts, community pulmonologists, respiratory nurses, as well as other healthcare providers who may be involved in the management of patients with IPF.
Email

Activity Title: 2019 Summer Pulmonary Updates: The Experts Weigh In

Accreditation Type: AMA PRA Category 1 Credit(s)™ 

Release Date: June 3, 2019

Expiration Date: June 2, 2020

Estimated Time to Complete Activity: 30 minutes

 

LEARNING OBJECTIVES

Upon completion of the activity, participants should be able to:

  • Review new information on the management of patients with IPF
  • Discuss the implication of this new information on current clinical practices for pulmonology clinicians

FACULTY 

A. Whitney Brown, MD

Director of Clinical Operations, Medical Director, Cystic Fibrosis, and Bronchiectasis Program

Inova Advanced Lung Disease and Transplant Program

Inova Fairfax Hospital

Falls Church, VA

 

Meena Kalluri, MD

Associate Professor, Department of Medicine, Pulmonary Division

University of Alberta

Edmonton, Alberta Canada 

 

Christopher S. King, MD, FACP, FCCP

Medical Director, Transplant and Advanced Lung Disease Critical Care Program

Inova Fairfax Hospital

Falls Church, VA

 

Luca Richeldi, MD

Head, Division of Respiratory Disease

Gemelli University Hospital

Rome, Italy

 

Mary Beth Scholand, MD

Associate Professor of Pulmonary Medicine

Director of the Interstitial Lung Disease Clinic

University of Utah

Salt Lake City, Utah

 

Joshua J. Solomon, MD

Associate Chief, Section of Critical Care

Associate Professor, Department of Medicine

Division of Pulmonary, Critical Care & Sleep Medicine

National Jewish Health

Denver, Colorado

 

METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

  1. There are no fees for participating in and receiving credit for this activity.
  2. Review the activity objectives and CME/CE information.
  3. Complete the CME/CE activity
  4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
  5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  6. Credit documentation/reporting: If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation—your CME/CE certificate will be available for download.

ACCREDITED PROVIDER

This activity is provided by The France Foundation.

 

TARGET AUDIENCE

This activity is intended for ILD experts, community pulmonologists, respiratory nurses, as well as other healthcare providers who may be involved in the management of patients with IPF.

 

ACCREDITATION STATEMENT

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

 

CREDIT DESIGNATION

Physicians: The France Foundation designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

DISCLOSURE POLICY

In accordance with the ACCME Standards for Commercial Support, The France Foundation requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. The France Foundation resolves all conflicts of interest to ensure independence, objectivity, balance and scientific rigor in all its educational programs. Furthermore, The France Foundation seeks to verify that all scientific research referred to, reported or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in healthcare and not those of a commercial interest.

 

Activity Staff Disclosures 

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

 

Faculty Disclosures 

The following faculty report that they have relevant financial relationships to disclose: 

  • A. Whitney Brown, MD, served as a consultant for Promedior and has served on the speakers bureau for Genentech. She has also participated in research for Promedior and Biogen.
  • Meena Kalluri, MD, has served on the advisory board for Boehringer Ingelheim Pharmaceuticals, Inc. and Roche and has participated in research funding for Roche.
  • Christopher King, MD, has served on the speakers’ bureau for Genentech.
  • Luca Richeldi, MD, has participated in clinical research for Boehringer Ingelheim Pharmaceuticals, Inc., and Genentech/Roche. He has also served as a consultant for Boehringer Ingelheim Pharmaceuticals, Inc. and Fibrogen, Nitto Pharmaceutical Industries, LTD. and Roche.
  • Mary Beth Scholand, MD, has served as a consultant for Boehringer Ingelheim Pharmaceuticals, Inc., and Genentech/Roche and has served on the speakers’ bureau for Genentech/Roche.
  • Josh Solomon, MD, has served on the speakers’ bureau for Genentech

DISCLOSURE OF UNLABELED USE

TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information. 

 

COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

 

DISCLAIMER 

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

 

COPYRIGHT INFORMATION

Copyright © 2019 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

  • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
  • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.

PRIVACY POLICY

The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation’s Privacy Policy can be viewed at http://www.francefoundation.com/privacy.

 

CONTACT INFORMATION

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.

Tags

Video | Pulmonary | CME (AMA PRA Category 1 Credit) | 0.50 - 30 mins | Cardiology | Internal Medicine | Family Medicine | Idiopathic Pulmonary Fibrosis | PILOTforPulmonary.org | Online |